Pfizer submits data for 3rd dose approval in US

Experimental drug that boosts immunotherapy shows promise in bladder cancer study
16 August 2021
Suicide deaths have risen by 20,000 over past 30 years around the world
16 August 2021

Pfizer submits data for 3rd dose approval in US

Pfizer and BioNTech on Monday submitted preliminary clinical data to US health authorities as part of their effort to seek authorization for a third dose of their COVID-19 vaccine for all Americans.

Comments are closed.